Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection. - Sulkowski, M. S.; Feld, J. J.; Lawitz, E.; Felizarta, F.; Corregidor, A. M.; Khalid, O.; Ghalib, R.; Smith, W. B.; Van Eygen, V.; Luo, D.; Vijgen, L.; Gamil, M.; et al. (Journal of Viral Hepatitis, 2018)